5-Amino-1MQ
5-Amino-1-methylquinolinium
Small molecule Amino Acids · MW: 178.23 g/mol
Amino Acids
Small molecule
Molecular Weight
178.23 g/mol
Half-life
~6 hours
Research Score
72.0
Studies
28
Storage
Room temperature, protect from light
What is 5-Amino-1MQ?
5-Amino-1MQ is a small molecule NNMT inhibitor that redirects cellular metabolism toward increased energy expenditure and reduced fat accumulation, representing a novel non-hormonal approach to weight management.
Key Benefits & Mechanisms
Reduces body fat without appetite changes, lowers cholesterol, increases NAD+ levels, improves metabolic efficiency, supports cellular energy production
Research Summary
Studies in diet-induced obese mice showed significant reductions in body weight, white adipose tissue mass, and cholesterol levels without changes in food intake. Works by inhibiting NNMT enzyme to increase NAD+ and activate sirtuins.
Related Peptides
CJC-1295
Growth Hormone Releasing Hormone Analog
CJC-1295 is a modified GHRH analog with an extended half-life due to Drug Affinity Complex (DAC) technology. It promotes sustained, pulsatile GH release, improving body composition, recovery, and sleep quality.
PerformanceAOD-9604
Anti-Obesity Drug (Modified GH Fragment)
AOD-9604 is a modified fragment of human growth hormone (HGH fragment 177-191) specifically designed for fat metabolism. It stimulates lipolysis and inhibits lipogenesis without affecting blood sugar or tissue growth, making it a targeted fat-loss peptide without typical GH side effects.
MetabolicMOTS-c
Mitochondrial Open Reading Frame of the 12S rRNA-c
MOTS-c is a mitochondrial-derived peptide that regulates metabolic homeostasis and exercise physiology. It activates AMPK, improves insulin sensitivity, and mimics the metabolic effects of exercise. Discovered at USC, it represents a new class of mitochondrial signaling peptides.
MetabolicOxyntomodulin
Endogenous glucagon-like peptide 1 and glucagon co-agonist peptide
Oxyntomodulin is a naturally occurring proglucagon-derived peptide that activates GLP-1 and glucagon pathways. It is a key research tool for appetite suppression and energy balance studies in obesity.
Weight Management